Institutional members access full text with Ovid®

Share this article on:

Ambulatory arterial stiffness index, pulse wave velocity and augmentation index – interchangeable or mutually exclusive measures?

Jerrard-Dunne, Paula; Mahmud, Azra; Feely, John

doi: 10.1097/HJH.0b013e3282f35265
Original papers: Blood vessels

Background The ambulatory arterial stiffness index (AASI) has been proposed as a novel measure of arterial stiffness and has been prospectively shown to predict stroke and cardiovascular death, but not cardiac death. This index has prompted considerable controversy as to whether it is a true measure of arterial stiffness.

Objective and methods The present study aimed to examine three different measures of arterial stiffness – pulse wave velocity (PWV; Complior), wave reflection [augmentation index (AIx)] and AASI – in a large hypertensive population, comparing their determinants and intercorrelations, both unadjusted and adjusted for confounders, and using Bland–Altman analysis to determine 95% confidence intervals for the ability of the AASI to predict PWV, the proposed gold standard of arterial stiffness.

Results The AASI correlated univariately with both PWV and the AIx in individuals overall (r = 0.28 for PWV and r = 0.24 for AIx; both P < 0.001) and in those with untreated or treated hypertension. Adjustment for age in the current study negated entirely the positive correlation between the AASI, PWV and AIx. Additional adjustment for confounders did not significantly alter these nonsignificant relationships. Furthermore, the 95% prediction limits for the AASI to predict PWV were ± 4.18 m/s and for the AASI to predict AIx were ± 25.4%, suggesting that the methods would not be interchangeable in a clinical setting. Direct comparative studies would be required to establish the relative predictive strength of each measure and whether combining measures can provide additional risk prediction. Until such data become available, we propose that the measures should not be considered interchangeable.

Department of Pharmacology and Therapeutics, Trinity College Dublin, Trinity Centre, St James's Hospital, Dublin, Ireland

Received 24 April, 2007

Revised 18 September, 2007

Accepted 15 October, 2007

Correspondence to Dr Paula Jerrard-Dunne, Department of Pharmacology & Therapeutics, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland Tel: +353 1 4162291; fax: +353 1 4539033; e-mail: jerrardp@tcd.ie

© 2008 Lippincott Williams & Wilkins, Inc.